Delaware
|
001-34637
|
20-1852016
|
||
(State or Other Jurisdiction of
Incorporation)
|
(Commission File Number)
|
(I.R.S. Employer
Identification No.)
|
25801 Industrial Boulevard, Suite B, Hayward, California
|
94545
|
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Exhibit No.
|
Description
|
|
99.1
|
Press Release dated February 10, 2015
|
|
99.2
|
Press Release dated February 10, 2015
|
Anthera Pharmaceuticals, Inc.
|
||
Date: February 11, 2015
|
By:
|
/s/ May Liu
|
May Liu
|
||
Senior Vice President, Finance and Administration
|
Exhibit No.
|
Description
|
|
99.1
|
Press Release dated February 10, 2015
|
|
99.2
|
Press Release dated February 10, 2015
|